World Medical Innovation Forum (WMIF) - Cardiovascular is organized by Partners HealthCare Innovation and would be held during May 01 - 03, 2017 at The Westin Copley Place, Boston, Massachusetts, United States of America. The target audience for this medical meeting basically for Cardiology and Vascular Surgeons.
More than 120 speakers - CEOs, government leaders, Harvard faculty - will chart the newest chapter in cardiovascular care in Boston on May 1-3. Speakers include the CEOs of Amgen, Boston Scientific, Medtronic, Philips, Cardinal Health, Abiomed, Alnylam, Bard, Editas, Edwards, Medicines Company, Mirna, Moderna, MyoKardia, Yumanity, Zoll, Boehringer Ingelheim, AHA, GE Healthcare, Siemens Healthcare, GE Ventures, FDA and CMS leaders, Verily CMO and dozens of top investors. Panels include seventeen plenary sessions, CEO Fireside Chats, First Look Sessions, and the Disruptive Dozen.
The 2017 World Medical Innovation Forum will feature the newest technologies to diagnose, treat and manage cardiovascular and cardiometabolic disease.he World Medical Innovation Forum is a global gathering of more than 1,000 senior health care leaders in the heart of Boston. It was established to respond to the intensifying transformation of health care and its impact on innovation. The Forum is rooted in the belief that no matter the magnitude of that change, the center of health care needs to be a shared, fundamental commitment to collaborative innovation – industry and academia working together to improve patient lives.